25 of the Best Oncologists Near Me

Douglas Gladstone is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.

Al Benson is an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 50 years. Dr. Benson is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Neuroendocrine Tumor, Carcinoid Syndrome, Liver Embolization, and Endoscopy. Dr. Benson is board certified in American Board Of Internal Medicine - Internal Medicine (Certified).

Jennifer Johnson is an Oncologist practicing medicine in Cherry Hill, New Jersey. Dr. Johnson is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Laryngeal Cancer, and Gastrostomy. Dr. Johnson is currently accepting new patients.

Surgery and management of patients with cancer is very complex and challenging. I enjoy working at Duke because of the breadth and quality of people we have here. I really feel like I’m working with the best when I’m working with my colleagues. I went into obstetrics and gynecology, because I enjoyed working with women patients. Then as a resident, I found that oncology patients were among the most gratifying to take care of because they appreciate so much everything you try to do for them. In high school and college, I was very interested in science and mathematics, and the human body and physiology. In college, meeting different types of people, I realized that I wanted a profession that gave me the opportunity to interact with all different kinds of people. My wife and I moved here 25 years ago and have never regretted it. It’s a great area to live. Dr. Berchuck is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Oophorectomy, and Tubal Ligation. Dr. Berchuck is board certified in American Board Of Obstetrics/Gynecology, Obstetrics & Gynecology and American Board Of Obstetrics/Gynecology, Gynecologic Oncology.

I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Erba is board certified in American Board Of Internal Med, Hematology.

Aaron Gerds is a Hematologist Oncology specialist and a Hematologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 24 years. Dr. Gerds is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gerds is board certified in American Board Of Internal Medicine, 2013.

I am a gynecologic oncologist at Duke. I see women who have ovarian cancer, uterine cancer, cervical cancer, and vulvar cancer. I also see women with precancerous conditions of the gynecologic organs, which includes cervical dysplasia, vaginal dysplasia, and masses of the ovary that may or may not be cancer. I am fairly direct and let people know what they are dealing with up front. On the other hand, I try to keep everything positive. At this point in my career, I’ve had a lot of experience and will let patients know that while there’s a full range of outcomes that could happen, I have seen a lot of positive examples based on their condition. If I had cancer or a family member of mine had cancer, I would absolutely want them to come to Duke. It’s not just the standard treatments that we offer here, but also the attention to detail and access to world-class clinical trials. Dr. Havrilesky is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Sertoli-Leydig Cell Tumor, Hysterectomy, and Oophorectomy. Dr. Havrilesky is board certified in American Board Of Obstetrics/Gynecology, Gynecologic Oncology and American Board Of Obstetrics/Gynecology, Obstetrics & Gynecology.

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine.

Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer. Dr. Zandberg is board certified in American Board Of Internal Medicine. Dr. Zandberg is currently accepting new patients.

Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee. Dr. Wagner is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Daria Babushok is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Babushok is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Acquired Amegakaryocytic Thrombocytopenia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Babushok is board certified in Hematology, 2014. Dr. Babushok is currently accepting new patients.

Barry Rosen is an Oncologist and a Surgical Oncologist practicing medicine in Dearborn, Michigan. He has been practicing medicine for over 49 years. Dr. Rosen is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Sertoli-Leydig Cell Tumor, Oophorectomy, and Salpingo-Oophorectomy. Dr. Rosen is board certified in Royal College Of Physicians And Surgeons Of Canada. Dr. Rosen is currently accepting new patients.

Michael Grunwald is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Grunwald is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Grunwald is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Hematology. Dr. Grunwald is currently accepting new patients.

Gottfried Von Keudell is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Von Keudell is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Von Keudell is board certified in American Board Of Internal Medicine.

Melinda Yushak is an Oncologist practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 17 years. Dr. Yushak is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Undifferentiated Pleomorphic Sarcoma, and Mesenchymoma. Dr. Yushak is board certified in American Board Of Internal Medicine, 2016.

Kristie Blum is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. She has been practicing medicine for over 29 years. Dr. Blum is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Blum is board certified in American Board Of Internal Medicine, 2004.

Peter Martin is an Internal Medicine provider practicing medicine in Brooklyn, New York. Dr. Martin is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Martin is currently accepting new patients.

Tracey Evans is a Hematologist and an Oncologist practicing medicine in East Norriton, Pennsylvania. Dr. Evans is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Thymectomy. Dr. Evans is board certified in Medical Oncology, Internal Medicine, Hospice And Palliative Medicine, and Hematology. Dr. Evans is currently accepting new patients.

Mary Mulcahy is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. She has been practicing medicine for over 33 years. Dr. Mulcahy is highly rated in 71 conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Neuroendocrine Tumor, Liver Embolization, and Pancreaticoduodenectomy. Dr. Mulcahy is board certified in American Board Of Internal Medicine - Medical Oncology (Certified).

Daniel Shevrin, MD, a medical oncologist at Endeavor Health, combines advanced cancer knowledge with compassion and personalized care. He helps patients understand complex diagnoses and collaborates on treatment plans that balance effectiveness and quality of life. Dr. Shevrin is actively involved in prostate cancer research, leading a genomics study to guide more precise therapies for men with advanced disease. He sees each patient as a person first and believes empathy is as essential as evidence-based care. Dr. Shevrin is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Hereditary Neuroblastoma, Non-Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Shevrin is board certified in American Board Of Internal Medicine.

Timothy Kuzel is an Oncologist practicing medicine in Orland Hills, Illinois, Illinois. He has been practicing medicine for over 42 years. Dr. Kuzel is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Melanoma, Cutaneous T-Cell Lymphoma (CTCL), Prostate Cancer, and Prostatectomy. Dr. Kuzel is board certified in American Board Of Internal Medicine - Internal Medicine (Certified).

Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sehgal is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Sehgal is currently accepting new patients.

John Villeneuve is an Oncologist and an Obstetrics and Gynecologist practicing medicine in West Reading, Pennsylvania. Dr. Villeneuve is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Endometrial Cancer, Endometrial Stromal Sarcoma, Bladder Reconstruction, and Hysterectomy. Dr. Villeneuve is board certified in American Board Of Obstetrics And Gynecology.

Joshua Meeks is an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 21 years. Dr. Meeks is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Reconstructive Urology Surgery. Dr. Meeks is board certified in American Board Of Urology - Urology (Certified).

Edouard Trabulsi is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Trabulsi is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Nephrectomy. Dr. Trabulsi is board certified in Urology. Dr. Trabulsi is currently accepting new patients.